Catalyst Wire Dossier Catalyst Wire Dossier

Efficib

sitagliptin and metformin hydrochloride · Merck Sharp and Dohme B.V
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Efficib, covering 2025-12-01 to 2025-12-01. Get the full timeline:

Most recent: EMA Authorised: Efficib (sitagliptin;metformin hydrochloride) — Merck Sharp and Dohme B.V

See pricing